The International Society for Gastrointestinal Hereditary Tumours Incorporated (InSiGHT) is an international multidisciplinary, scientific organisation. Its mission is to improve the quality of care of patients and their families with any condition resulting in hereditary gastrointestinal tumours. This mission will be accomplished by:

  1. Encouragement of research into all aspects of gastrointestinal hereditary tumour syndromes.
  2. Education of physicians and other healthcare professionals in the molecular genetics and clinical management of gastrointestinal hereditary tumour syndromes.
  3. Assistance for institutions and individuals interested in beginning or maintaining a registry for families with gastrointestinal hereditary tumour syndromes.
  4. Provision of a forum for the presentation of data, discussion of controversial areas involved in the care of patients and their families, and facilitation of collaborative studies.

The InSiGHT Variant Interpretation Committee

06-01-2014 14:53:34

read >

Review of the impact of registration and screening

23-12-2013 12:23:06

Review of the impact of registration and screening on colorectal cancer incidence and mortality in familial adenomatous polyposis and Lynch syndrome. Studies consistently report that registration and screening result in a reduction of CRC incidence and mortality in patients with FAP and LS (level 2a evidence, grade B recommendation). Funding and managerial support for hereditary CRC registries should be made available.

read >

Inside InSiGHT

11-12-2012 00:06:28

Electronic newsletter InSiGHT.......

read >

2013 Meeting Australia

06-12-2012 16:08:48

The 2013 InSiGHT meeting will be organized from 28th - 31st August 2013 in Cairns Convention Centre, Cairns, Australia.

read >

Running for hereditary cancer

28-11-2011 16:19:00

On November 6th 2011, Dr. Frederik Hes completed the New York City marathon.

read >